CareDx, Inc. (CDNA)
Health Care ยท Services-Medical Laboratories
CareDx, Inc. (CDNA) is listed on Nasdaq, where its shares have traded since July 17, 2014. SentiSense covers CareDx, Inc. in the Health Care sector, and its Standard Industrial Classification is Services-Medical Laboratories. John W. Hanna is its chief executive officer. The company reports 765 employees, and its corporate website is www.caredx.com.
About CareDx, Inc.
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically it generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.
Latest reported results
CareDx, Inc. reported revenue of $139.4 million for Q3 FY2026, up 39.3% from the same period a year earlier.
Institutional ownership
In 13F filings for the quarter ended June 30, 2026, 220 institutions reported holding CDNA, with 52.8 million shares worth $1.5 billion in aggregate. The largest reported holders were BlackRock, Vanguard and State Street. Of the 5 largest reported holders, 2 added shares and 3 reduced their positions during the quarter.
More on CDNA
- CDNA sentiment: whether news and social coverage of CareDx, Inc. leans bullish or bearish, and the stories driving it.
- CDNA ownership: all 220 reporting institutions, plus insider and congressional trades.
- CDNA financials: revenue, net income, operating margin and free cash flow through Q3 FY2026.
Frequently asked questions
What does CareDx, Inc. do?
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers.
What sector is CDNA in?
SentiSense classifies CareDx, Inc. in the Health Care sector, and its Standard Industrial Classification is Services-Medical Laboratories.
Where does CDNA stock trade?
CareDx, Inc. (CDNA) is listed on Nasdaq, where its shares have traded since July 17, 2014.
Who is the CEO of CareDx, Inc.?
John W. Hanna is the chief executive officer of CareDx, Inc..